# BPN14770 Single Ascending Dose Study in Healthy Male and Female Subjects

> **NCT02648672** · PHASE1 · COMPLETED · sponsor: **Tetra Discovery Partners** · enrollment: 32 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** BPN14770
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02648672
- **Lead sponsor:** Tetra Discovery Partners
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2016-02
- **Final completion:** 2016-07
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2017-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02648672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02648672, "BPN14770 Single Ascending Dose Study in Healthy Male and Female Subjects". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02648672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*